Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Vimentin Antibodies:
anti-Mouse (Murine) Vimentin Antibodies:
anti-Rat (Rattus) Vimentin Antibodies:
Go to our pre-filtered search.
Human Polyclonal Vimentin Primary Antibody for IHC (p), WB - ABIN3042344
Quan, Du, Hou, Wang, Zhang: Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma. in Oncology reports 2017
Show all 86 Pubmed References
Human Monoclonal Vimentin Primary Antibody for IHC (p), WB - ABIN3043673
Zhu, Liu, Li, Liu, Wang, Sun, Xiong, Jiang, Zheng, Hu: Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility. in Carcinogenesis 2014
Show all 77 Pubmed References
Human Polyclonal Vimentin Primary Antibody for FACS, IF (cc) - ABIN672786
Liu, Han, Wang, Feng: Down-regulation of Wnt10a affects odontogenesis and proliferation in mesenchymal cells. in Biochemical and biophysical research communications 2013
Show all 29 Pubmed References
Dog (Canine) Polyclonal Vimentin Primary Antibody for ICC, IF - ABIN152563
Johnstone, Mongroo, Rich, Schupp, Bowser, Delemos, Tobias, Liu, Hannigan, Rustgi: Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation. in Molecular and cellular biology 2008
Show all 24 Pubmed References
Human Polyclonal Vimentin Primary Antibody for ELISA, ICC - ABIN6269441
Li, Zhang, Sun, Sun, Shi, Liu, Liu: MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells. in International journal of oncology 2016
Show all 14 Pubmed References
Human Polyclonal Vimentin Primary Antibody for IF, IHC - ABIN6712041
Fang, Wang, Zhang, Qu, Liu, Qian, Zhu, Zhou, Wang: Transcatheter arterial embolization promotes liver tumor metastasis by increasing the population of circulating tumor cells. in OncoTargets and therapy 2013
Show all 10 Pubmed References
Human Monoclonal Vimentin Primary Antibody for ICC, FACS - ABIN335382
Brussee, Smit, Koopman, Wijga, Kerkhof, Corver, Vos, Gerritsen, Grobbee, Brunekreef, Merkus, de Jongste: Interrupter resistance and wheezing phenotypes at 4 years of age. in American journal of respiratory and critical care medicine 2004
Show all 7 Pubmed References
Human Monoclonal Vimentin Primary Antibody for ICC, FACS - ABIN335380
Pieper, Schaart, Krimpenfort, Henderik, Moshage, van de Kemp, Ramaekers, Berns, Bloemendal: Transgenic expression of the muscle-specific intermediate filament protein desmin in nonmuscle cells. in The Journal of cell biology 1989
Show all 5 Pubmed References
Chicken Monoclonal Vimentin Primary Antibody for ICC, IHC (fro) - ABIN1042493
Ramaekers, Huysmans, Schaart, Moesker, Vooijs: Tissue distribution of keratin 7 as monitored by a monoclonal antibody. in Experimental cell research 1987
Show all 5 Pubmed References
Chicken Monoclonal Vimentin Primary Antibody for ICC, IHC (fro) - ABIN1042494
Raats, Pieper, Vree Egberts, Verrijp, Ramaekers, Bloemendal: Assembly of amino-terminally deleted desmin in vimentin-free cells. in The Journal of cell biology 1990
Show all 5 Pubmed References
VIM is downregulated and E-cad is upregulated in T1 stage non-small-cell lung cancer, suggesting that a mesenchymal-epithelial transition may take place in the early-stage of tumor development
aberrant methylation of SOX1 and VIM promoters may be potential biomarkers for noninvasive detection of hepatocellular carcinoma and metastasis
cell surface vimentin was identified as a candidate surface receptor mediating stiffness-dependent adhesion of Listeria monocytogenes to human microvascular endothelial cells.
shape and inner structure of these mutant filaments is significantly altered
Vimentin and Sam68, are identified as bona fide SRMS substrates through in vitro and in vivo assays.
Review includes a brief historical account of early studies that unveiled vimentin as a unique component of the cell cytoskeleton followed by an overview of the physiological vimentin functions
Involved in clear cell renal carcinoma vasculogenic mimicry and metastasis through association with TR4 nuclear receptor and miR490-3p
Study reported for the first time that one of the proteins that binds to P5 in U251 glioblastoma cells is vimentin, and the present findings indicated that P5 may be an attractive target for novel molecular targeted therapy of glioblastoma.
Mechanistic analyses revealed that FOXD1 expressed its oncogenic characteristics through activating Vimentin in non-small cell lung cancer cells.
Results showed that BPIFB1 expression markedly inhibited NPC cell migration, invasion, and lung-metastatic abilities. Additionally, identification of two BPIFB1-interacting proteins, VTN and VIM, showed that BPIFB1 reduced VTN expression and the formation of a VTN-integrin alphaV complex in NPC cells, leading to inhibition of the FAK/Src/ERK signalling pathway.
Study in HeLa cells revealed that Nup88 can affect the phosphorylation status of vimentin, which may contribute to the Nup88-dependent multinucleated phenotype through changing the organization of vimentin.
EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression
The progression of the endometrioid carcinoma may occur in the setting of various molecular changes, in particular, with decreased expression of E-cadherin and b-catenin and high expression of vimentin, or in the absence of vimentin, utilizing other mechanisms of regulation of proliferative and metastatic potential.
A significant correlation between mRNA levels of Twist1, fibronectin and vimentin was evident. Although their expression was inversely proportional, no association was observed between Twist1 and E-cadherin expression
Our study suggests that the expression of vimentin in early stages of oral cancer may be beneficial, although not sufficient to achieve transformation
this study identified vimentin as a direct molecular target that mediates simvastatin-induced cell death in 2 different cancer cell lines.
This study measured the effects of vimentin expression on the mechano-elastic and migratory properties of the highly invasive breast carcinoma cell line MDA231. It demonstrated that vimentin stiffens cells and enhances cell migration in dense cultures, but exerts little or no effect on the migration of sparsely plated cells.
Positive vimentin expression could serve as a poor prognostic marker in gastric cancer[review, meta-analysis]
High vimentin expression is associated with pancreatic cancer.
the HDAC inhibitors augmented both Ecadherin and vimentin expression and their effects varied in different cholangiocarcinoma cell lines. Therefore, the clinical use of HDAC inhibitors in biliary cancer should be considered cautiously
mutation of the serine sites phosphorylated in vimentin during mitosis alters intermediate filament protein expression but has no effect on astrocyte morphology or proliferation, and leads to increased neuronal differentiation of neural progenitor cells.
The Listeria monocytogenes virulence factor InlF was found to bind vimentin and was necessary for optimal bacterial colonization of the brain.
MAGE-G1 interacted with fascin 1 or vimentin in P19 cells after a 6-day retinoic acid-induced neuronal differentiation.
Results found that the absence of vimentin impairs spontaneous endothelial differentiation in vitro and have furthering the understanding of the regulators of differentiation.
Results indicate that vimentin orchestrates the healing by controlling fibroblast proliferation, TGF-beta1-Slug signaling, and epithelial-mesenchymal transition (EMT) processing, and all of which in turn govern the required keratinocyte activation.
Protein phosphatase 1 is a key protein serine/threonine phosphatase that controls vimentin Ser-56 dephosphorylation in smooth muscle.
These findings identify vimentin as a positive regulator of stemness in the developing mouse mammary gland and in breast cancer cells.
This study is the first to show that vimentin has an important role in tumor metastasis in vivo in the setting of pre-diabetes and endogenous hyperinsulinemia.
These findings identify two specific sites on vimentin that are phosphorylated by Cadmium.
The expression level of vimentinin liver cirrhotic tissues were significantly higher than that in chronic hepatitis tissues.
both arthritis-susceptible and -resistant mice can generate cellular and humoral immunity to Vim.
vimentin knockout neurons were insensitive to the axonotrophic effects of Clostridium botulinum C3 exoenzyme
These findings suggest that Plk1 regulates smooth muscle contraction by modulating vimentin phosphorylation at Ser-56.
findings thus show that the inability to produce GFAP and Vim affects normal retinal physiology and that the effect of IF deficiency on retinal cell survival differs, depending on the underlying pathologic condition
these findings identify a hereto-unappreciated role for serine-38 phosphorylated vimentin as an important determinant of myofibroblast sensitivity to Withaferin A.
Vimentin expression increased after traumatic brain injury and was positively correlated with edema and neurological impairments.
Annexin, lamin, and vimentin were identified as universal dystrophic markers
Astrocytes deficient of GFAP and vimentin showed decreased Notch signal sending competence and altered expression of Notch signaling pathway-related genes
Absence of GFAP, or both GFAP and vimentin, alters Alzheimer's disease-induced changes in gene expression profile of astrocytes, showing a compensation of the decrease of neuronal support genes and a trend for a higher inflammatory expression profile
Vimentin is not only a major organizing element of the intermediate filament network but is also involved in both binding and uptake of C3 exoenzyme.
Taken together these findings suggest that reactive oxygen species and vimentin integrate early wound signals to orchestrate the formation of collagen-based projections that guide regenerative growth during efficient wound repair.
Knockdown of filamin A or vimentin in normal cells profoundly suppresses apical extrusion of the neighbouring transformed cells.
Immunocytochemistry for Vimentin detection in nuclei of IVF and NT bovine embryos
These results indicate that the inner mass differentiates dynamically in blastocysts, as reflected by the expression of vimentin; higher vimentin expression may reflect the higher developmental competence of embryos.
an intact vimentin intermediate filament network contributes to the maintenance of the chondrocyte phenotype
Vimentin- like transcript was expressed in both chordocytes and chordoblasts, whereas the elastin- like transcript was uniquely expressed in the chordoblasts lining the notochordal sheath.
This study evaluated the expression pattern of vimentin in testes of mature Arabian stallions and correlated its distribution with grade of seminiferous tubule impairment as indicated by a Johnsen score.
ANXA2 can interact with vimentin and enhance porcine reproductive and respiratory syndrome virus (PRRSV) growth. This contributes to the regulation of PRRSV replication in infected cells and may have implications for the future antiviral strategies.
As the inner cell mass forms the epiblast, SSEA1 is lost and VIMENTIN is lost and re-expressed.
These observations indicate that vimentin serves as a putative receptor for Japanese encephalitis virus in porcine kidney cells.
Interaction of nucleocapsid protein of transmissible gastroenteritis virus with host vimentin is required for virus infection.
protein(s) that associated with RPTPbeta in response to IGF-I and IGFBP-2 in vascular smooth muscle cells
This study demonstrates that maternal VIM, as a genomic protector, is crucial for nuclear reprogramming in porcine cloned embryos.
Vim expression in corneal epithelium is found in a cell population composed of highly motile cells.
These differentially expressed proteins associated with key mechanisms involved in atherosclerosis and signaling mechanisms related with vitamin E.
This gene encodes a member of the intermediate filament family. Intermediate filamentents, along with microtubules and actin microfilaments, make up the cytoskeleton. The protein encoded by this gene is responsible for maintaining cell shape, integrity of the cytoplasm, and stabilizing cytoskeletal interactions. It is also involved in the immune response, and controls the transport of low-density lipoprotein (LDL)-derived cholesterol from a lysosome to the site of esterification. It functions as an organizer of a number of critical proteins involved in attachment, migration, and cell signaling. Mutations in this gene causes a dominant, pulverulent cataract.
, vimentin 1
, class-III intermediate microfilament